Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by الشركة الأردنية لانتاج الأدويةfiledCriticalالشركة الأردنية لانتاج الأدوية
Priority to JO2006253ApriorityCriticalpatent/JO2568B1/en
Application grantedgrantedCritical
Publication of JO2568B1publicationCriticalpatent/JO2568B1/en
Chitosan silicone dioxide coprecipitate composition, method of production thereof, pharmaceutical composition comprising the chitosan silicone dioxide coprecipitate composition and use of the chitosan silicone dioxide coprecipitate composition for manufacturing a sustained or immediate release formulation
JO2006253A2006-07-272006-07-27Novel Pharmaceutical Chitosan for use in Solid Dosage Forms
JO2568B1
(en)
Derivatives of dimethyl-oxo-dihydro-(pyridine-3 or 4-yl)- phenyl- 6- methyl-6 - phenyl -[1,3]- oxazine -2- one, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
Pyridopyrimidine compounds, pharmaceutical compositions comprising them, the compounds for use as medicaments and use of the compounds in the manufacture of medicaments
Derivatives of 4-pyrimidinesulfamide, process for their preparation, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
Benzo[d] oxazole-2-carboxamido-4-phenyl-thiophene-carboxylate derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
Pyrazolyl-thiophene derivatives , pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for improving cognitive function in animals
2,3-dihydro-pyrido-1,4-oxazine and 2,3-dihydro-4-oxa-1,9-diazaphenanthrene derivatives, processes for their preparation and pharmaceutical compositions comprising them
3,7-dihydropurine-2,6-dione derivatives, processes for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
Process for producing high purity safinamide or ralfinamide, use thereof in the preparation of medicaments and pharmaceutical formulations containing them
Derivatives of (2-hydroxy-2-phenyl-1-pyrrolidin-1-ylmethyl-ethyl)carbamic acid phenyl ester, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
C7-fluoro substituted tetracycline compound, pharmaceutical composition comprising it and its use in the manufacture of medicaments for treating infection caused by bacteria
Derivatives of 1h-benzoimidazol-2-yl-propyl-methyl-amino-ethyl-5-aryl-bicyclo[2.2.2]oct-5-en-2-ol, pharmaceutical compositions comprising them and their use in the manufacture of medicaments